GT200700050A - Profarmacos de penem - Google Patents

Profarmacos de penem

Info

Publication number
GT200700050A
GT200700050A GT200700050A GT200700050A GT200700050A GT 200700050 A GT200700050 A GT 200700050A GT 200700050 A GT200700050 A GT 200700050A GT 200700050 A GT200700050 A GT 200700050A GT 200700050 A GT200700050 A GT 200700050A
Authority
GT
Guatemala
Prior art keywords
profarms
penem
propharms
hydrapts
biodisponibility
Prior art date
Application number
GT200700050A
Other languages
English (en)
Inventor
Katherine Elizabeth Brighty
Anthony Marfat
Dale Gordon Mcleod
John Paul O Donnell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GT200700050A publication Critical patent/GT200700050A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A PROFÁRMACOS DE SULOPENEM CON BIODISPONIBILIDAD POR VÍA ORAL, Y SUS SOLVATOS E HIDRATOS, SU PREPARACIÓN, SU FORMULACIÓN Y SU USO PARA TRATAR Y PREVENIR LA INFECCIÓN DE MAMÍFEROS TALES COMO SERES HUMANOS. T2007
GT200700050A 2006-06-28 2007-06-25 Profarmacos de penem GT200700050A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80600006P 2006-06-28 2006-06-28
US91158707P 2007-04-13 2007-04-13

Publications (1)

Publication Number Publication Date
GT200700050A true GT200700050A (es) 2008-02-01

Family

ID=38463109

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200700050A GT200700050A (es) 2006-06-28 2007-06-25 Profarmacos de penem

Country Status (29)

Country Link
US (2) US7795243B2 (es)
EP (1) EP2044085B1 (es)
JP (2) JP4397435B2 (es)
KR (1) KR101060448B1 (es)
AP (1) AP2008004705A0 (es)
AR (1) AR061646A1 (es)
AT (1) ATE493419T1 (es)
AU (1) AU2007263519B2 (es)
BR (1) BRPI0712740A2 (es)
CA (1) CA2655485C (es)
CL (1) CL2007001910A1 (es)
CR (1) CR10467A (es)
DE (1) DE602007011622D1 (es)
DK (1) DK2044085T3 (es)
EA (1) EA200870584A1 (es)
EC (1) ECSP088947A (es)
GT (1) GT200700050A (es)
HK (1) HK1134928A1 (es)
IL (1) IL195383A0 (es)
MA (1) MA30568B1 (es)
MX (1) MX2009000116A (es)
NL (1) NL2000715C2 (es)
NO (1) NO20090392L (es)
PE (1) PE20080940A1 (es)
SV (1) SV2008003139A (es)
TN (1) TNSN08537A1 (es)
TW (1) TW200816999A (es)
UY (1) UY30439A1 (es)
WO (1) WO2008001212A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
WO2009108704A1 (en) * 2008-02-25 2009-09-03 Semafore Pharmaceuticals, Inc. O-alkylated pi-3 kinase inhibitor prodrug combination
KR100916052B1 (ko) 2009-02-24 2009-09-08 코오롱건설주식회사 진공이송 쓰레기 수거시스템의 쓰레기 배출밸브
SG10201600910YA (en) * 2009-08-10 2016-03-30 Bhi Ltd Partnership Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
US11554112B2 (en) * 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
MX2021009755A (es) * 2019-02-13 2021-11-17 Iterum Therapeutics International Ltd Combinaciones de compuestos beta-lactámicos y probenecid, y usos de los mismos.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619924A (en) * 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
US4870170A (en) * 1985-10-17 1989-09-26 Pfizer Inc. Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
US5013729A (en) * 1987-05-11 1991-05-07 Pfizer Inc. Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
GB8713515D0 (en) * 1987-06-10 1987-07-15 Erba Farmitalia Methoxymethyl compounds
US4874877A (en) * 1988-04-19 1989-10-17 Pfizer Inc. Process for optically active 3-(methane-sulfonyloxy)thiolane and analogs
WO1992003443A1 (en) * 1990-08-20 1992-03-05 Suntory Limited Antibacterial penem compounds
ES2140393T3 (es) * 1990-08-20 2000-03-01 Suntory Ltd Compuestos de penem.
WO2004067532A1 (ja) 2003-01-31 2004-08-12 Meiji Seika Kaisha, Ltd. 新規カルバペネム誘導体
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
EP2043728A2 (en) * 2006-07-11 2009-04-08 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug

Also Published As

Publication number Publication date
AU2007263519B2 (en) 2011-05-19
CL2007001910A1 (es) 2008-01-11
US20090042853A1 (en) 2009-02-12
KR101060448B1 (ko) 2011-08-29
MX2009000116A (es) 2009-01-23
DK2044085T3 (da) 2011-03-07
WO2008001212A3 (en) 2008-03-20
TNSN08537A1 (fr) 2010-04-14
SV2008003139A (es) 2010-01-12
CA2655485A1 (en) 2008-01-03
WO2008001212A2 (en) 2008-01-03
JP5152527B2 (ja) 2013-02-27
US20080009474A1 (en) 2008-01-10
EP2044085A2 (en) 2009-04-08
IL195383A0 (en) 2009-08-03
NL2000715A1 (nl) 2008-01-02
EA200870584A1 (ru) 2009-06-30
AU2007263519A1 (en) 2008-01-03
EP2044085B1 (en) 2010-12-29
NO20090392L (no) 2009-01-27
CA2655485C (en) 2011-08-02
AP2008004705A0 (en) 2008-12-31
CR10467A (es) 2009-01-19
JP2010013468A (ja) 2010-01-21
BRPI0712740A2 (pt) 2012-06-05
MA30568B1 (fr) 2009-07-01
UY30439A1 (es) 2008-01-31
ECSP088947A (es) 2009-01-30
JP2009542616A (ja) 2009-12-03
ATE493419T1 (de) 2011-01-15
DE602007011622D1 (en) 2011-02-10
US7795244B2 (en) 2010-09-14
KR20090015147A (ko) 2009-02-11
TW200816999A (en) 2008-04-16
PE20080940A1 (es) 2008-07-09
NL2000715C2 (nl) 2008-03-11
AR061646A1 (es) 2008-09-10
US7795243B2 (en) 2010-09-14
HK1134928A1 (en) 2010-05-20
JP4397435B2 (ja) 2010-01-13

Similar Documents

Publication Publication Date Title
GT200700050A (es) Profarmacos de penem
CL2008003593A1 (es) Compuestos derivados de isoxazolo-piridazina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos cognitivos como el alzheimer
AR059978A1 (es) Composiciones farmaceuticas
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
MY145117A (en) Disposable diaper
BRPI0411528A (pt) uso de isomalte como prebiótico
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
CR20130455A (es) Composiciones para el tratamiento de tumores
PA8836801A1 (es) Polipeptidos g-csf de bovino modificados y sus usos
CR20120183A (es) PIPERIDINAS SUSTITUIDAS QUE AUMENTAN LA ACTIVIDAD DE p53 Y SUS USOS
CL2012000248A1 (es) Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina.
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
CR8919A (es) Analogos de tetrapeptidos
UY33616A (es) Compuestos con estructura de imidazotriazinona
CL2009001874A1 (es) Uso de bacillus subtilis qst713 nrrl b-21661 para formular una composición probiótica para un animal; y composición probiotica de bacillus subtilis qst713 nrrl b-21661.
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
ECSP109923A (es) Bromhidrato de bupropion y aplicaciones terapéuticas
UY29417A1 (es) Agentes endoparasiticidas
AR053775A1 (es) Nonadepsipeptidos acilados ii
SV2006002384A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
AR072425A1 (es) Uso de nifurtimox para el tratamiento de giardiasis
HN2012000585A (es) Composiciones y metodos para tratar infecciones bacterianas utilizando ceftarolina
IT1395351B1 (it) Formulazioni orali ad elevata biodisponibilita' orale costituite da miscele di frazioni lipofile e idrofile ottenute a partire dalla propoli
CL2011001399A1 (es) Compuestos derivados de morfina-6-glucuronido; medicamento; composicion farmaceutica que los comprende; compuestos intermediarios; y su uso en el tratamiento o prevencion del dolor.
CL2010001589A1 (es) Compuestos derivados de 3-ciano-pirrolidin-fenil-oxazolidinonas; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.